Clinical trial
A Ph1a/1b, First in Human, Participant and Investigator-blind Sponsor-unblinded Randomized Placebo-controlled Multiple Dose Study of EDP1867 in Healthy Volunteers & Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma
NCT04927195 is registered in ClinicalTrials.gov with Evelo Biosciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Ph1a/1b, First in Human, Participant and Investigator-blind Sponsor-unblinded Randomized Placebo-controlled Multiple Dose Study of EDP1867 in Healthy Volunteers & Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma
- Lead sponsor
- Evelo Biosciences, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 23, 2021
- Completion date
- February 28, 2022
- Enrollment
- 52 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.